Cargando…

Landscape of Immune-Related Markers and Potential Therapeutic Targets in Soft Tissue Sarcoma

SIMPLE SUMMARY: Despite being a group of rare diseases of mesenchymal origin, soft tissue sarcomas are heterogenous and display varying clinical behavior, and depending on the subtype, intermediate- and high-grade sarcomas have significant metastatic potential, making it difficult to establish a sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roszik, Jason, Mustachio, Lisa Maria, Livingston, John A., Groisberg, Roman, Carmagnani Pestana, Roberto, Subbiah, Vivek, Conley, Anthony P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534178/ https://www.ncbi.nlm.nih.gov/pubmed/34680396 http://dx.doi.org/10.3390/cancers13205249

Ejemplares similares

Precision Oncology in Sarcomas: Divide and Conquer
por: Carmagnani Pestana, Roberto, et al.
Publicado: (2019)

Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets
por: Roszik, Jason, et al.
Publicado: (2019)

Analysis of histology-agnostic targets among soft tissue and bone sarcomas in the AACR GENIE database
por: Pestana, Roberto Carmagnani, et al.
Publicado: (2023)

Single-Cell Sequencing: Current Applications in Precision Onco-Genomics and Cancer Therapeutics
por: Mustachio, Lisa Maria, et al.
Publicado: (2022)

Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)
por: Moyers, Justin T., et al.
Publicado: (2023)

Targeting KRAS in Cancer: Promising Therapeutic Strategies
por: Mustachio, Lisa Maria, et al.
Publicado: (2021)

Current Targeted Therapies for the Fight against Non-Small Cell Lung Cancer
por: Mustachio, Lisa Maria, et al.
Publicado: (2020)

Opportunities for Single-Cell Sequencing Technologies and Data Science
por: Mustachio, Lisa Maria, et al.
Publicado: (2020)

Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials
por: Groisberg, Roman, et al.
Publicado: (2017)

The proteomic landscape of soft tissue sarcomas
por: Burns, Jessica, et al.
Publicado: (2023)

Molecular landscape and therapeutic alterations in Asian soft‐tissue sarcoma patients
por: Gan, Meifu, et al.
Publicado: (2022)

High-Throughput Architecture for Discovering Combination Cancer Therapeutics
por: Gianni, Matt, et al.
Publicado: (2018)

MAGE-A3 Is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma
por: Conley, Anthony P., et al.
Publicado: (2019)

On the Relevance of Soft Tissue Sarcomas Metabolic Landscape Mapping
por: Esperança-Martins, Miguel, et al.
Publicado: (2022)

Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors
por: Dembla, Vikas, et al.
Publicado: (2017)

Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes
por: Roszik, Jason, et al.
Publicado: (2017)

Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
por: Nacev, Benjamin A., et al.
Publicado: (2022)

Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
por: Carmagnani Pestana, Roberto, et al.
Publicado: (2023)

Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case Report
por: Conley, Anthony P., et al.
Publicado: (2017)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
por: Seong, Gyuhee, et al.
Publicado: (2023)

Therapeutic Targets for Bone and Soft-Tissue Sarcomas
por: Miwa, Shinji, et al.
Publicado: (2019)

Editorial: New therapeutics for soft tissue sarcomas
por: Weetall, Marla, et al.
Publicado: (2023)

Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas
por: Groisberg, Roman, et al.
Publicado: (2017)

Prognostic Impacts of Hypoxic Markers in Soft Tissue Sarcoma
por: Smeland, Eivind, et al.
Publicado: (2012)

Cancer Genetics and Therapeutic Opportunities in Urologic Practice
por: Adashek, Jacob J., et al.
Publicado: (2020)

Retroperitoneal Soft Tissue Sarcoma: Emerging Therapeutic Strategies
por: de Bree, Eelco, et al.
Publicado: (2023)

Limb conservation in extremity soft tissue sarcomas with vascular involvement
por: Ramamurthy, Rajaraman, et al.
Publicado: (2009)

Expression of hypoxic markers and their prognostic significance in soft tissue sarcoma
por: KIM, JEUNG IL, et al.
Publicado: (2015)

Characterizing inflammatory markers in highly aggressive soft tissue sarcomas
por: Hashimoto, Kazuhiko, et al.
Publicado: (2022)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

A quest for therapeutic antigens in bone and soft tissue sarcoma
por: Kawaguchi, Satoshi, et al.
Publicado: (2005)

The challenge of finding new therapeutic avenues in soft tissue sarcomas
por: Kasper, Bernd
Publicado: (2019)

The immune landscape of undifferentiated pleomorphic sarcoma
por: Lazcano, Rossana, et al.
Publicado: (2022)

Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials
por: Livingston, J. Andrew, et al.
Publicado: (2016)

Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma
por: Grinshpun, Albert, et al.
Publicado: (2019)

The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets
por: Rocchi, Laura, et al.
Publicado: (2014)

Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma
por: Planas‐Paz, Lara, et al.
Publicado: (2023)

Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets
por: Kim, Jihyun, et al.
Publicado: (2018)

Retroperitoneal soft tissue sarcoma
por: Zepeda, Ernesto, et al.
Publicado: (2007)

Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qbtonjt1rm7sdl7tkqr20o6lv9